English

23, 24 MAY
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PARTICIPANTS PROFILE

Product categories

Branded generics: 48.3%

Biological products: 34.5%

Biosimilars: 20.7%

Hospital products: 34.5%

Innovative medicines: 55.0%

more info




Partnering Strategy/Interests

In-licensing: 55.2%

Out-licensing: 46.6%

Co-marketing: 37.9%

Co-promotion: 37.9%

Co-development: 53.4%

more info




Therapeutic areas

Cardiovascular: 51.7%

CNS: 50.0%

Infectious diseases: 32.8%

Pain: 48.3%

Respiratory: 36.2%

more info



PARTICIPANTS 2019

Branded generics: 48.3%

Biological products: 34.5%

Biosimilars: 20.7%

Diagnostics: 5.2%

Distribution: 8.6%

Drug delivers technol.: 0.0%

Generics: 24.1%

Herbal medicines: 15.5%

Homeopathy: 3.4%

Hospital products: 34.5%

Innovative medicines: 55.0%

Medical devices: 14.7%

Veterinary: 6.0%

Sponsor

patrocinador

partner